MK-0249
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-0249, covering 2015-06-08 to 2015-06-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023) [Phase 1]